ARTICLE | Top Story
FDA approves QLT's Visudyne
April 12, 2000 7:00 AM UTC
The FDA granted marketing approval for Visudyne verteporfin photodynamic therapy to treat wet age-related macular degeneration (AMD). Visudyne was developed by QLT PhotoTherapeutics (TSE:QLT; QLTI) an...